Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 16Dermatologic 1

Conditions

Melanoma 35Neoplasm Metastasis 12Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma, Merkel Cell 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Carcinoma, Basal Cell 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Esophageal Neoplasms 3Carcinosarcoma 3Breast Neoplasms 3Stomach Neoplasms 2Skin Neoplasms 2Sarcoma 2

Interventions

pembrolizumab 4motexafin gadolinium 1cabozantinib 1Vorinostat 1Taxes 1Specimen Handling 1Ritonavir 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Indinavir 1Drug Therapy 1Doxorubicin 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Specimen Handling × Dermatologic × Clear all
NCT05136196 2026-06-03

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡